View in EDS PDF Full Text

ALT neuroblastoma chemoresistance due to telomere dysfunction-induced ATM activation is reversible with ATM inhibitor AZD0156.

Saved in:
Bibliographic Details
Title: ALT neuroblastoma chemoresistance due to telomere dysfunction-induced ATM activation is reversible with ATM inhibitor AZD0156.
Authors: Koneru B; Cancer Center, School of Medicine, Texas Tech University Health Sciences Center, Lubbock, TX 79430, USA.; Department of Pediatrics, School of Medicine, Texas Tech University Health Sciences Center, Lubbock, TX 79430, USA.; Department of Cell Biology and Biochemistry, School of Medicine, Texas Tech University Health Sciences Center, Lubbock, TX 79430, USA., Farooqi A; Cancer Center, School of Medicine, Texas Tech University Health Sciences Center, Lubbock, TX 79430, USA., Nguyen TH; Cancer Center, School of Medicine, Texas Tech University Health Sciences Center, Lubbock, TX 79430, USA., Chen WH; Cancer Center, School of Medicine, Texas Tech University Health Sciences Center, Lubbock, TX 79430, USA., Hindle A; Cancer Center, School of Medicine, Texas Tech University Health Sciences Center, Lubbock, TX 79430, USA.; Department of Cell Biology and Biochemistry, School of Medicine, Texas Tech University Health Sciences Center, Lubbock, TX 79430, USA., Eslinger C; Cancer Center, School of Medicine, Texas Tech University Health Sciences Center, Lubbock, TX 79430, USA., Makena MR; Cancer Center, School of Medicine, Texas Tech University Health Sciences Center, Lubbock, TX 79430, USA., Burrow TA; Cancer Center, School of Medicine, Texas Tech University Health Sciences Center, Lubbock, TX 79430, USA., Wilson J; Early Oncology, R&D AstraZeneca, Cambridge CB10 1XL, UK., Smith A; Early Oncology, R&D AstraZeneca, Cambridge CB10 1XL, UK., Pilla Reddy V; Clinical Pharmacology and Quantitative Pharmacology, Biopharmaceuticals R&D, AstraZeneca, Cambridge SG8 6EE, UK., Cadogan E; Early Oncology, R&D AstraZeneca, Cambridge CB10 1XL, UK., Durant ST; Early Oncology, R&D AstraZeneca, Cambridge CB10 1XL, UK., Reynolds CP; Cancer Center, School of Medicine, Texas Tech University Health Sciences Center, Lubbock, TX 79430, USA. patrick.reynolds@ttuhsc.edu.; Department of Pediatrics, School of Medicine, Texas Tech University Health Sciences Center, Lubbock, TX 79430, USA.; Department of Cell Biology and Biochemistry, School of Medicine, Texas Tech University Health Sciences Center, Lubbock, TX 79430, USA.; Department of Internal Medicine, School of Medicine, Texas Tech University Health Sciences Center, Lubbock, TX 79430, USA.
Source: Science translational medicine [Sci Transl Med] 2021 Aug 18; Vol. 13 (607).
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
Journal Info: Publisher: American Association for the Advancement of Science Country of Publication: United States NLM ID: 101505086 Publication Model: Print Cited Medium: Internet ISSN: 1946-6242 (Electronic) Linking ISSN: 19466234 NLM ISO Abbreviation: Sci Transl Med Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Links:
  – Type: pdflink
Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 34408079
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: ALT neuroblastoma chemoresistance due to telomere dysfunction-induced ATM activation is reversible with ATM inhibitor AZD0156.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Koneru+B%22">Koneru B</searchLink>; Cancer Center, School of Medicine, Texas Tech University Health Sciences Center, Lubbock, TX 79430, USA.; Department of Pediatrics, School of Medicine, Texas Tech University Health Sciences Center, Lubbock, TX 79430, USA.; Department of Cell Biology and Biochemistry, School of Medicine, Texas Tech University Health Sciences Center, Lubbock, TX 79430, USA.<br /><searchLink fieldCode="AU" term="%22Farooqi+A%22">Farooqi A</searchLink>; Cancer Center, School of Medicine, Texas Tech University Health Sciences Center, Lubbock, TX 79430, USA.<br /><searchLink fieldCode="AU" term="%22Nguyen+TH%22">Nguyen TH</searchLink>; Cancer Center, School of Medicine, Texas Tech University Health Sciences Center, Lubbock, TX 79430, USA.<br /><searchLink fieldCode="AU" term="%22Chen+WH%22">Chen WH</searchLink>; Cancer Center, School of Medicine, Texas Tech University Health Sciences Center, Lubbock, TX 79430, USA.<br /><searchLink fieldCode="AU" term="%22Hindle+A%22">Hindle A</searchLink>; Cancer Center, School of Medicine, Texas Tech University Health Sciences Center, Lubbock, TX 79430, USA.; Department of Cell Biology and Biochemistry, School of Medicine, Texas Tech University Health Sciences Center, Lubbock, TX 79430, USA.<br /><searchLink fieldCode="AU" term="%22Eslinger+C%22">Eslinger C</searchLink>; Cancer Center, School of Medicine, Texas Tech University Health Sciences Center, Lubbock, TX 79430, USA.<br /><searchLink fieldCode="AU" term="%22Makena+MR%22">Makena MR</searchLink>; Cancer Center, School of Medicine, Texas Tech University Health Sciences Center, Lubbock, TX 79430, USA.<br /><searchLink fieldCode="AU" term="%22Burrow+TA%22">Burrow TA</searchLink>; Cancer Center, School of Medicine, Texas Tech University Health Sciences Center, Lubbock, TX 79430, USA.<br /><searchLink fieldCode="AU" term="%22Wilson+J%22">Wilson J</searchLink>; Early Oncology, R&D AstraZeneca, Cambridge CB10 1XL, UK.<br /><searchLink fieldCode="AU" term="%22Smith+A%22">Smith A</searchLink>; Early Oncology, R&D AstraZeneca, Cambridge CB10 1XL, UK.<br /><searchLink fieldCode="AU" term="%22Pilla+Reddy+V%22">Pilla Reddy V</searchLink>; Clinical Pharmacology and Quantitative Pharmacology, Biopharmaceuticals R&D, AstraZeneca, Cambridge SG8 6EE, UK.<br /><searchLink fieldCode="AU" term="%22Cadogan+E%22">Cadogan E</searchLink>; Early Oncology, R&D AstraZeneca, Cambridge CB10 1XL, UK.<br /><searchLink fieldCode="AU" term="%22Durant+ST%22">Durant ST</searchLink>; Early Oncology, R&D AstraZeneca, Cambridge CB10 1XL, UK.<br /><searchLink fieldCode="AU" term="%22Reynolds+CP%22">Reynolds CP</searchLink>; Cancer Center, School of Medicine, Texas Tech University Health Sciences Center, Lubbock, TX 79430, USA. patrick.reynolds@ttuhsc.edu.; Department of Pediatrics, School of Medicine, Texas Tech University Health Sciences Center, Lubbock, TX 79430, USA.; Department of Cell Biology and Biochemistry, School of Medicine, Texas Tech University Health Sciences Center, Lubbock, TX 79430, USA.; Department of Internal Medicine, School of Medicine, Texas Tech University Health Sciences Center, Lubbock, TX 79430, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101505086%22">Science translational medicine</searchLink> [Sci Transl Med] 2021 Aug 18; Vol. 13 (607).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Association+for+the+Advancement+of+Science%22">American Association for the Advancement of Science </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101505086 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1946-6242 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2219466234%22">19466234 </searchLink><i>NLM ISO Abbreviation: </i>Sci Transl Med <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=34408079
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1126/scitranslmed.abd5750
    Languages:
      – Code: eng
        Text: English
    Titles:
      – TitleFull: ALT neuroblastoma chemoresistance due to telomere dysfunction-induced ATM activation is reversible with ATM inhibitor AZD0156.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Koneru B
      – PersonEntity:
          Name:
            NameFull: Farooqi A
      – PersonEntity:
          Name:
            NameFull: Nguyen TH
      – PersonEntity:
          Name:
            NameFull: Chen WH
      – PersonEntity:
          Name:
            NameFull: Hindle A
      – PersonEntity:
          Name:
            NameFull: Eslinger C
      – PersonEntity:
          Name:
            NameFull: Makena MR
      – PersonEntity:
          Name:
            NameFull: Burrow TA
      – PersonEntity:
          Name:
            NameFull: Wilson J
      – PersonEntity:
          Name:
            NameFull: Smith A
      – PersonEntity:
          Name:
            NameFull: Pilla Reddy V
      – PersonEntity:
          Name:
            NameFull: Cadogan E
      – PersonEntity:
          Name:
            NameFull: Durant ST
      – PersonEntity:
          Name:
            NameFull: Reynolds CP
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 18
              M: 08
              Text: 2021 Aug 18
              Type: published
              Y: 2021
          Identifiers:
            – Type: issn-electronic
              Value: 1946-6242
          Numbering:
            – Type: volume
              Value: 13
            – Type: issue
              Value: 607
          Titles:
            – TitleFull: Science translational medicine
              Type: main
ResultId 1